Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14194620
Abstract: Simple Summary Recent advances in molecular medicine have indicated G-protein coupled receptors (GPCRs) as possible therapeutic targets in ovarian cancer. The cellular effects of GPCRs are determined by regulator of G protein signaling (RGS) proteins.… read more here.
Keywords: rgs2; hgsoc; expression; expression rgs2 ... See more keywords